These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 15869543)

  • 21. Correlation between Dermatology Life Quality Index and Minor test and differences in their levels over time in patients with axillary hyperhidrosis treated with botulinum toxin type A.
    Skroza N; Bernardini N; La Torre G; La Viola G; Potenza C
    Acta Dermatovenerol Croat; 2011; 19(1):16-20. PubMed ID: 21489361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial.
    Naumann MK; Hamm H; Lowe NJ;
    Br J Dermatol; 2002 Dec; 147(6):1218-26. PubMed ID: 12452874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repetitive injections of botulinum toxin A continuously increase the duration of efficacy in primary axillary hyperhidrosis: a retrospective analysis in 101 patients.
    Brehmer F; Lockmann A; Grönemeyer LL; Kretschmer L; Schön MP; Thoms KM
    J Dtsch Dermatol Ges; 2015 Aug; 13(8):799-805. PubMed ID: 26176740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months.
    Frasson E; Brigo F; Acler M; Didonè G; Vicentini S; Bertolasi L
    Arch Dermatol; 2011 Jan; 147(1):122-3. PubMed ID: 21242408
    [No Abstract]   [Full Text] [Related]  

  • 25. Dose-finding, safety, and tolerability study of botulinum toxin type B for the treatment of hyperfunctional glabellar lines.
    Carruthers A; Carruthers J; Flynn TC; Leong MS
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S60-8. PubMed ID: 17241416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of botulinum toxin type A in the treatment of focal axillary hyperhidrosis.
    Absar MS; Onwudike M
    Dermatol Surg; 2008 Jun; 34(6):751-5. PubMed ID: 18318723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial.
    Ghei M; Maraj BH; Miller R; Nathan S; O'Sullivan C; Fowler CJ; Shah PJ; Malone-Lee J
    J Urol; 2005 Nov; 174(5):1873-7; discussion 1877. PubMed ID: 16217327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival.
    Campanati A; Sandroni L; Gesuita R; Giuliano A; Giuliodori K; Marconi B; Ganzetti G; Offidani A
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):917-21. PubMed ID: 21054569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of methantheline bromide (Vagantin(®) ) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trial.
    Müller C; Berensmeier A; Hamm H; Dirschka T; Reich K; Fischer T; Rzany B
    J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1278-84. PubMed ID: 23004926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Durability of botulinum toxin treatment for axillary hyperhidrosis.
    Moffat CE; Hayes WG; Nyamekye IK
    Eur J Vasc Endovasc Surg; 2009 Aug; 38(2):188-91. PubMed ID: 19395290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin A and B: a comparative dosing study for spasmodic dysphonia.
    Blitzer A
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):836-8. PubMed ID: 16360499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Botulinum toxin in the treatment of focal hyperhidrosis].
    Schnider P; Moraru E; Kittler H; Voller B; Kranz G; Auff E
    Wien Klin Wochenschr; 2001; 113 Suppl 4():36-41. PubMed ID: 15506051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experience with botulinum toxin therapy for axillary hyperhidrosis and comparison to modelled data for endoscopic thoracic sympathectomy - A quality of life and cost effectiveness analysis.
    Gibbons JP; Nugent E; O'Donohoe N; Maher B; Egan B; Feeley M; Tierney S
    Surgeon; 2016 Oct; 14(5):260-4. PubMed ID: 26071930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy of botulinum toxin A in the treatment of axillary and palmar hyperhidrosis: 10 cases].
    Maillard H; Briand N; Bara C; Celerier P
    Ann Dermatol Venereol; 2003 May; 130(5):511-3. PubMed ID: 12843826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The place of botulinum toxin type A in the treatment of focal hyperhidrosis.
    Lowe N; Campanati A; Bodokh I; Cliff S; Jaen P; Kreyden O; Naumann M; Offidani A; Vadoud J; Hamm H
    Br J Dermatol; 2004 Dec; 151(6):1115-22. PubMed ID: 15606505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin type a versus topical 20% aluminum chloride for the treatment of moderate to severe primary focal axillary hyperhidrosis.
    Flanagan KH; King R; Glaser DA
    J Drugs Dermatol; 2008 Mar; 7(3):221-7. PubMed ID: 18380203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin type B in the treatment of residual limb hyperhidrosis for lower limb amputees: a pilot study.
    Kern U; Kohl M; Seifert U; Schlereth T
    Am J Phys Med Rehabil; 2011 Apr; 90(4):321-9. PubMed ID: 21765248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis: efficacy and duration with repeated treatments.
    Lowe PL; Cerdan-Sanz S; Lowe NJ
    Dermatol Surg; 2003 May; 29(5):545-8. PubMed ID: 12752526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower relapse rate of botulinum toxin A therapy for axillary hyperhidrosis by dose increase.
    Karamfilov T; Konrad H; Karte K; Wollina U
    Arch Dermatol; 2000 Apr; 136(4):487-90. PubMed ID: 10768647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diode laser hair removal does not interfere with botulinum toxin A treatment against axillary hyperhidrosis.
    Paul A; Kranz G; Schindl A; Kranz GS; Auff E; Sycha T
    Lasers Surg Med; 2010 Mar; 42(3):211-4. PubMed ID: 20333738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.